Evidence map›Paper›PMID 29463040›Full record

ArticleMolecules (Basel, Switzerland)2018

Structural Insights into σ₁ Receptor Interactions with Opioid Ligands by Molecular Dynamics Simulations.

Mateusz Kurciński, Małgorzata Jarończyk, Piotr F J Lipiński, Jan Cz Dobrowolski, Joanna Sadlej

Open access · goldAbstract read
In one paragraph

Article in Molecules (Basel, Switzerland), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.2field-weighted citation impact, top 48% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. The Role of Sigmar1 in Autophagy Regulation and Disease Therapy.International journal of molecular sciences · 2026
    Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Mateusz KurcińskiFaculty of Chemistry, University of Warsaw, Pasteur Str.1, 02-093 Warsaw, Poland. mkurc@chem.uw.edu.pl.
Małgorzata JarończykNational Medicines Institute, 30/34 Chełmska Str., 00-725 Warsaw, Poland. m.jaronczyk@nil.gov.pl.
Piotr F J LipińskiDepartment of Neuropeptides, Mossakowski Medical Research Center, Polish Academy of Sciences, 02-106 Warsaw, Poland. plipin@icm.edu.pl.
Jan Cz DobrowolskiNational Medicines Institute, 30/34 Chełmska Str., 00-725 Warsaw, Poland. j.dobrowolski@nil.gov.pl.
Joanna SadlejNational Medicines Institute, 30/34 Chełmska Str., 00-725 Warsaw, Poland. j.sadlej@uksw.edu.pl.
Narodowy Instytut Leków · PLMossakowski Medical Research Institute, Polish Academy of Sciences · PLUniversity of Warsaw · PL

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Despite considerable advances over the past years in understanding the mechanisms of action and the role of the σ₁ receptor, several questions regarding this receptor remain unanswered. This receptor has been identified as a useful target for the treatment of a diverse range of diseases, from various central nervous system disorders to cancer. The recently solved issue of the crystal structure of the σ₁ receptor has made elucidating the structure-activity relationship feasible. The interaction of seven representative opioid ligands with the crystal structure of the σ₁ receptor (PDB ID: 5HK1) was simulated for the first time using molecular dynamics (MD). Analysis of the MD trajectories has provided the receptor-ligand interaction fingerprints, combining information on the crucial receptor residues and frequency of the residue-ligand contacts. The contact frequencies and the contact maps suggest that for all studied ligands, the hydrophilic (hydrogen bonding) interactions with Glu172 are an important factor for the ligands' affinities toward the σ₁ receptor. However, the hydrophobic interactions with Tyr120, Val162, Leu105, and Ile124 also significantly contribute to the ligand-receptor interplay and, in particular, differentiate the action of the agonistic morphine from the antagonistic haloperidol.

Indexed as

Analgesics, OpioidBinding SitesCrystallography, X-RayHumansHydrogen BondingHydrophobic and Hydrophilic InteractionsLigandsMolecular Dynamics SimulationMorphineProtein BindingReceptors, sigmaStructure-Activity RelationshipAnalgesics, OpioidLigandsMorphineReceptors, sigmafentanylhaloperidolmolecular dynamicsmorphineopioid ligandssigma receptor

Identifiers

PMID29463040
PMCPMC6017133
OpenAlexW2791525246

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.